Five-Year Retention of Perampanel and Polytherapy Patterns: 328 Patients From a Single Center in South Korea

BACKGROUND AND PURPOSE: Perampanel (PER) is an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist used to treat focal and generalized epilepsy. Comprehensive data from real-world settings with long-term follow-ups are still scarce. This study aimed to determine the factors related to PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyung-Il, Hwang, Sungeun, Son, Hyoshin, Chu, Kon, Jung, Ki-Young, Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329921/
https://www.ncbi.nlm.nih.gov/pubmed/37417431
http://dx.doi.org/10.3988/jcn.2022.0338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329921/
https://www.ncbi.nlm.nih.gov/pubmed/37417431
http://dx.doi.org/10.3988/jcn.2022.0338

Ejemplares similares